Security Snapshot

LINDE PLC - Common Stock (LIN) Institutional Ownership

CUSIP: G54950103

13F Institutional Holders and Ownership History from Q4 2018 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

2,231

Shares (Excl. Options)

377,121,854

Price

$495.76

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.1%
Share change
-2,896,991
Value change
-$761,117,186
Number of holders
2,231
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
463,758,684
SEC-reported price per share
$501.87
Insider filing price
$501.87
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • LIN - LINDE PLC - Common Stock is tracked under CUSIP G54950103.
  • 2231 institutions reported positions in Q1 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 2,094 to 2,231 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $161,660,560,506 to $186,881,016,725.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 2231 institutions filings for Q1 2026.

Open SEC evidence

Security key

G54950103

Latest holder period

Q1 2026

13F holders

2,231

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
LIN
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD CAPITAL MANAGEMENT LLC 7.5% $17,718,416,203 34,874,653 Vanguard Capital Management 31 Mar 2026

As of 31 Mar 2026, 2,231 institutional investors reported holding 377,121,854 shares of LINDE PLC - Common Stock (LIN). This represents 81% of the company’s total 463,758,684 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
49%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8% 36,872,272 -0.74% 0.32% $18,279,797,902
VANGUARD CAPITAL MANAGEMENT LLC 6.5% 30,233,070 0% 0.37% $14,988,346,783
STATE STREET CORP 4.2% 19,625,129 +1.4% 0.34% $9,730,040,642
Capital Research Global Investors 3.5% 16,051,934 +58% 1.2% $7,958,106,621
VANGUARD PORTFOLIO MANAGEMENT LLC 2.6% 12,289,282 0% 0.32% $6,092,534,445
GEODE CAPITAL MANAGEMENT, LLC 2.6% 11,832,240 +4.2% 0.37% $5,867,730,974
PRICE T ROWE ASSOCIATES INC /MD/ 2.1% 9,846,511 +0.64% 0.56% $4,881,508,000
FMR LLC 1.9% 8,997,328 -16% 0.24% $4,460,515,601
MORGAN STANLEY 1.6% 7,358,093 +3.8% 0.22% $3,647,850,222
JPMORGAN CHASE & CO 1.3% 6,255,468 -29% 0.21% $3,123,105,735
Capital International Investors 1.2% 5,441,647 -28% 0.63% $2,698,285,855
Invesco Ltd. 1.1% 5,273,814 -2.4% 0.4% $2,614,545,904
WELLINGTON MANAGEMENT GROUP LLP 1.1% 5,152,523 -0.68% 0.48% $2,554,414,802
Bank of New York Mellon Corp 1.1% 5,100,531 -4.5% 0.47% $2,528,639,207
Freemont Capital Pte Ltd 1.1% 5,083,319 0% 51% $2,520,106,227
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.97% 4,498,652 +6.9% 0.46% $2,230,251,717
NORTHERN TRUST CORP 0.96% 4,471,719 +0.06% 0.29% $2,216,899,410
FRANKLIN RESOURCES INC 0.96% 4,437,326 +20% 0.54% $2,199,848,944
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.88% 4,100,714 -20% 0.74% $2,082,763,888
Nuveen, LLC 0.88% 4,077,362 +8.6% 0.55% $2,021,392,743
GOLDMAN SACHS GROUP INC 0.85% 3,921,515 +22% 0.26% $1,944,130,290
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.83% 3,865,271 +2.6% 0.29% $1,916,438,134
WELLS FARGO & COMPANY/MN 0.82% 3,784,457 -0.19% 0.37% $1,876,182,180
AMERIPRISE FINANCIAL INC 0.8% 3,703,417 +16% 0.43% $1,836,417,630
DEUTSCHE BANK AG\ 0.78% 3,638,121 -7.7% 0.6% $1,803,634,868

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
30
Latest
Q1 2026
Rows shown
1-25 of 30
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 377,121,854 $186,881,016,725 -$761,117,186 $495.76 2,231
2025 Q4 379,069,058 $161,660,560,506 +$1,815,812,304 $426.39 2,094
2025 Q3 373,840,964 $177,508,784,696 -$4,958,941,523 $475.00 2,081
2025 Q2 383,639,155 $179,946,500,715 +$2,034,152,713 $469.18 2,060
2025 Q1 379,854,518 $176,788,077,458 -$3,378,295,417 $465.64 2,022
2024 Q4 388,247,934 $162,563,008,391 -$1,597,465,910 $418.67 1,973
2024 Q3 386,711,948 $184,364,855,854 +$433,263,272 $476.86 1,882
2024 Q2 385,431,388 $169,095,726,371 -$2,822,182,299 $438.81 1,822
2024 Q1 391,884,101 $181,866,947,347 -$3,200,121,433 $464.32 1,817
2023 Q4 398,286,994 $163,513,849,431 -$545,147,548 $410.71 1,760
2023 Q3 401,135,122 $149,371,146,376 -$1,145,288,005 $372.35 1,604
2023 Q2 403,963,359 $153,754,343,853 +$409,168,934 $381.08 1,563
2023 Q1 402,159,743 $142,879,838,086 +$142,329,441,468 $355.44 1,435
2022 Q4 442,561 $144,354,546 +$112,104,151 $326.18 11
2022 Q3 97,745 $26,353,062 -$1,910,907 $269.59 6
2022 Q2 102,200 $29,961,452 +$3,344,640 $287.53 8
2022 Q1 92,570 $29,569,869 +$4,585,128 $319.43 6
2021 Q4 78,216 $27,096,414 +$1,788,270 $346.43 6
2021 Q3 73,054 $21,432,659 -$117,281 $293.38 6
2021 Q2 73,464 $21,238,480 +$193,118 $289.10 7
2021 Q1 72,796 $20,393,091 +$8,685,504 $280.14 6
2020 Q4 41,162 $10,929,415 +$7,458,395 $263.51 7
2020 Q3 12,296 $2,928,041 +$2,176,747 $238.13 5
2020 Q2 3,155 $669,151 +$63,621 $212.11 4
2020 Q1 2,855 $493,830 +$69,877 $173.00 4
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .